Scientific Reports (Jun 2023)

Disparity in the use of Alzheimer's disease treatment in Southern Brazil

  • Maisa De Marco,
  • Ana Laura Brandi,
  • Andrei Bieger,
  • Bárbara Krug,
  • Analuiza Camozzato,
  • Paulo D. Picon,
  • Marcia Lorena Fagundes Chaves,
  • Raphael Machado Castilhos

DOI
https://doi.org/10.1038/s41598-023-36604-4
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Alzheimer's disease (AD) treatment is freely available in the Brazilian public health system. However, the prescription pattern and its associated factors have been poorly studied in our country. We reviewed all granted requests for AD treatment in the public health system in October 2021 in the Rio Grande do Sul (RS) state, Southern Brazil. We performed a spatial autocorrelation analysis with the population-adjusted patients receiving any AD medication as the outcome and correlated it with several socioeconomic variables. 2382 patients with AD were being treated during the period analyzed. The distribution of the outcome variable was not random (Moran's I 0.17562, P <.0001), with the most developed regions having a higher number of patients/100,000 receiving any AD medication. We show that although AD medications are available through the public health system, there is a clear disparity between regions of RS state. Factors related to socioeconomic development partly explain this finding.